SynthesisEuropean journal of clinical pharmacology2026

Determinants of circulating PCSK9 levels and the efficacy of PCSK9 inhibitor therapies in chronic kidney disease: a systematic review.

Tatjana Ábel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.